Revolution Medicines, Inc. (RVMD) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$147.21
Price Target
$154.80
Target Range
$73.00 — $200.00
Analyst Rating
Buy
Forward P/E—
Trailing P/E-24.7x
Forward PEG—
Implied Growth-26.9%
Median Target$163.50
Analyst Spread82.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$73
-50.4%
Consensus
$155
+5.2%
Bull Case
$200
+35.9%
RVMD Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Revolution Medicines, Inc. (RVMD) has a Wall Street consensus price target of $154.80, based on estimates from 22 covering analysts. With the stock currently trading at $147.21, this represents a potential upside of +5.2%. The company has a market capitalization of $29.00B.
Analyst price targets range from a low of $73.00 to a high of $200.00, representing a 82% spread in expectations. The median target of $163.50 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 21 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, RVMD trades at a trailing P/E of -24.7x. Analysts expect EPS to grow -26.9% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+34.4%
Avg Forward P/E14.8x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MRSNMersana Therapeutics, Inc. | $145M | $29.08 | $10.00 | -65.6% | Buy | — | 19 |
 ARVNArvinas, Inc. | $679M | $10.61 | $13.00 | +22.5% | Buy | — | 26 |
 BDTXBlack Diamond Therapeutics, Inc. | $163M | $2.87 | $8.00 | +178.7% | Buy | — | 11 |
 TNGXTango Therapeutics, Inc. | $3.3B | $24.20 | $22.75 | -6.0% | Buy | — | 10 |
 NUVLNuvalent, Inc. | $6.7B | $101.47 | $144.40 | +42.3% | Buy | — | 14 |
 KYMRKymera Therapeutics, Inc. | $6.8B | $82.71 | $117.06 | +41.5% | Buy | — | 26 |
 AMGNAmgen Inc. | $177.9B | $329.59 | $350.76 | +6.4% | Buy | 14.8x | 38 |
 MGNXMacroGenics, Inc. | $199M | $3.15 | $6.00 | +90.5% | Buy | — | 22 |
 ERASErasca, Inc. | $2.8B | $9.99 | $13.60 | +36.1% | Buy | — | 11 |
 ACLXArcellx, Inc. | $6.7B | $115.07 | $112.45 | -2.3% | Hold | — | 18 |
Upside Potential Comparison
BDTXMGNXNUVLKYMRERASARVNAMGNACLXFull RVMD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RVMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RVMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RVMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRVMD — Frequently Asked Questions
Quick answers to the most common questions about buying RVMD stock.
What is the RVMD stock price target for 2026?
The consensus price target for RVMD is $154.8, close to the current price of $147.21 (5.2% implied move). Based on 22 analyst estimates, the stock appears fairly valued near current levels.
Is RVMD a buy, sell, or hold?
RVMD has a consensus rating of "Buy" based on 22 Wall Street analysts. The rating breakdown is predominantly bullish, with 21 Buy/Strong Buy ratings. The consensus 12-month price target of $154.8 implies 5.2% upside from current levels.
Is RVMD stock overvalued or undervalued?
RVMD's current price is $147.21 with a consensus target of $154.8 (5.2% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
How high can RVMD stock go?
The most bullish Wall Street analyst has a price target of $200 for RVMD, while the most conservative target is $73. The consensus of $154.8 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover RVMD stock?
RVMD is well covered by analysts, with 22 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 20 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the RVMD stock forecast?
The 12-month RVMD stock forecast based on 22 Wall Street analysts shows a consensus price target of $154.8, with estimates ranging from $73 (bear case) to $200 (bull case). The median consensus rating is "Buy".
Should I buy RVMD stock?
RVMD appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $154.8 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do RVMD price targets vary so much?
RVMD analyst price targets range from $73 to $200, a 82% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $154.8 consensus represents the middle ground.